Trial Protocol of a Phase II Study of mFOLFOXIRI after Metastasectomy in Patients with Oligometastatic Colorectal Cancer (FANTASTIC Study)-Reference-Cited by-同舟云学术

Trial Protocol of a Phase II Study of mFOLFOXIRI after Metastasectomy in Patients with Oligometastatic Colorectal Cancer (FANTASTIC Study)

Published:2024-07-25 Issue:3 Volume:8 Page:246-252
ISSN:2432-3853
Container-title:Journal of the Anus, Rectum and Colon
language:en
Short-container-title:J Anus Rectum Colon

Author:

Kataoka Kozo¹,Yamada Takeshi²,Yamazaki Kentaro³,Mori Keita⁴,Matsuhashi Nobuhisa⁵,Shiozawa Manabu⁶,Iwai Takuma²,Goto Masahiro⁷,Yasui Masayoshi⁸,Takii Yasumasa⁹,Suto Takeshi¹⁰,Takamizawa Yasuyuki¹¹,Takase Naoto¹²,Sharma Shruti¹³,Ensor Joe¹³,Jurdi Adham¹³,Liu Minetta C.¹³,Ikeda Masataka¹,Kanemitsu Yukihide¹¹

Affiliation:

1. Division of Lower GI, Department of Gastroenterological Surgery, Hyogo Medical University

2. Department of Gastrointestinal Surgery, Nippon Medical School

3. Division of Gastrointestinal Oncology, Shizuoka Cancer Center

4. Department of Biostatistics, Clinical Research Center, Shizuoka Cancer Center

5. Department of Gastroenterological Surgery・Pediatric Surgery, Gifu University School of Medicine

6. Department of Gastrointestinal Surgery, Kanagawa Cancer Center

7. The Second Department of Internal Medicine, Osaka Medical College Hospital

8. Department of Gastroenterological Surgery, Osaka International Cancer Institute

9. Department of Surgery, Niigata Cancer Center Hospital

10. Department of Gastrointestinal Surgery, Yamagata Prefectural Central Hospital

11. Department of Colorectal Surgery, National Cancer Center Hospital

12. Department of Medical Oncology, Takarazuka City Hospital

13. Natera, Inc.

Publisher

The Japan Society of Coloproctology

Link

https://www.jstage.jst.go.jp/article/jarc/8/3/8_2024-025/_pdf

Reference31 articles.

1. 1. Zellweger M, Abdelnour-Berchtold E, Krueger T, et al. Surgical treatment of pulmonary metastasis in colorectal cancer patients: Current practice and results. Crit Rev Oncol Hematol. 2018 Sep; 127: 105-16.

2. 2. Fong Y, Fortner J, Sun RL, et al. Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer: analysis of 1001 consecutive cases. Ann Surg. 1999 Sep; 230 (3): 309-18; discussion 318-21.

3. 3. Nordlinger B, Sorbye H, Glimelius B, et al. Perioperative FOLFOX4 chemotherapy and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC 40983): long-term results of a randomised, controlled, phase 3 trial. Lancet Oncol. 2013 Nov; 14 (12): 1208-15.

4. 4. Hasegawa K, Saiura A, Takayama T, et al. Adjuvant Oral Uracil-Tegafur with Leucovorin for Colorectal Cancer Liver Metastases: A Randomized Controlled Trial. PLoS One. 2016 Sep; 11 (9): e0162400.

5. 5. Primrose J, Falk S, Finch-Jones M, et al. Systemic chemotherapy with or without cetuximab in patients with resectable colorectal liver metastasis: the New EPOC randomised controlled trial. Lancet Oncol. 2014 May; 15 (6): 601-11.